These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 21106209

  • 1. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
    Sicras Mainar A, Galera Llorca J, Muñoz Ortí G, Navarro Artieda R.
    Med Clin (Barc); 2011 Feb 26; 136(5):183-91. PubMed ID: 21106209
    [Abstract] [Full Text] [Related]

  • 2. [Relationship of polymedication in controlling blood pressure: compliance, persistence, costs and incidence of new cardiovascular events].
    Sicras Mainar A, Muñoz Ortí G, Font Ramos B, Majós Oró N, Navarro Artieda R, Ibáñez Nolla J.
    Med Clin (Barc); 2013 Jul 21; 141(2):53-61. PubMed ID: 22766057
    [Abstract] [Full Text] [Related]

  • 3. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Jul 21; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 4. Economic evaluation of single-pill combination of indapamide and amlodipine in the treatment of arterial hypertension in the Polish setting.
    Kawalec P, Holko P, Stawowczyk E, Borowiec Ł, Filipiak KJ.
    Kardiol Pol; 2015 Jul 21; 73(9):768-80. PubMed ID: 25987296
    [Abstract] [Full Text] [Related]

  • 5. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH.
    Curr Med Res Opin; 2015 Dec 21; 31(12):2287-96. PubMed ID: 26397178
    [Abstract] [Full Text] [Related]

  • 6. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B, Predel HG, Gillessen A, Hacke C, Vor dem Esche J, Rippin G, Noetel A, Randerath O.
    High Blood Press Cardiovasc Prev; 2020 Apr 21; 27(2):157-164. PubMed ID: 32219670
    [Abstract] [Full Text] [Related]

  • 7. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany.
    Breitscheidel L, Ehlken B, Kostev K, Oberdiek MS, Sandberg A, Schmieder RE.
    J Med Econ; 2012 Apr 21; 15(1):155-65. PubMed ID: 22035215
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives.
    Yang W, Chang J, Kahler KH, Fellers T, Orloff J, Wu EQ, Bensimon AG.
    Curr Med Res Opin; 2010 Sep 21; 26(9):2065-76. PubMed ID: 20629600
    [Abstract] [Full Text] [Related]

  • 9. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 Sep 21; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 10. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
    Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S.
    Med Care; 2010 May 21; 48(5):418-25. PubMed ID: 20393367
    [Abstract] [Full Text] [Related]

  • 11. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
    Balu S, Simko RJ, Quimbo RM, Cziraky MJ.
    Curr Med Res Opin; 2009 Nov 21; 25(11):2765-75. PubMed ID: 19785511
    [Abstract] [Full Text] [Related]

  • 12. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA, Hilleman DE.
    Manag Care; 2010 Jul 21; 19(7):36-42. PubMed ID: 20672530
    [Abstract] [Full Text] [Related]

  • 13. Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy.
    Yang W, Kahler KH, Fellers T, Orloff J, Chang J, Bensimon AG, Wu EQ, Fan CP, Yu AP.
    J Med Econ; 2011 Jul 21; 14(3):267-78. PubMed ID: 21446895
    [Abstract] [Full Text] [Related]

  • 14. [Cost of arterial hypertension according to levels of morbidity in primary care setting].
    Sicras-Mainar A, Navarro-Artieda R.
    Med Clin (Barc); 2009 Sep 05; 133(8):290-5. PubMed ID: 19596366
    [Abstract] [Full Text] [Related]

  • 15. Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe--the HEALTH model.
    Schwander B, Gradl B, Zöllner Y, Lindgren P, Diener HC, Lüders S, Schrader J, Villar FA, Greiner W, Jönsson B.
    Value Health; 2009 Sep 05; 12(6):857-71. PubMed ID: 19508663
    [Abstract] [Full Text] [Related]

  • 16. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R, Michailidis P.
    Clin Ther; 2011 Sep 05; 33(9):1190-203. PubMed ID: 21885126
    [Abstract] [Full Text] [Related]

  • 17. A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination.
    Masi S, Kobalava Z, Veronesi C, Giacomini E, Degli Esposti L, Tsioufis K.
    Adv Ther; 2024 Jan 05; 41(1):182-197. PubMed ID: 37864626
    [Abstract] [Full Text] [Related]

  • 18. Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.
    Bangalore S, Ley L.
    Expert Opin Pharmacother; 2012 Feb 05; 13(3):345-55. PubMed ID: 22220825
    [Abstract] [Full Text] [Related]

  • 19. Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy.
    Mathes J, Kostev K, Gabriel A, Pirk O, Schmieder RE.
    Int J Clin Pharmacol Ther; 2010 Mar 05; 48(3):173-83. PubMed ID: 20197011
    [Abstract] [Full Text] [Related]

  • 20. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.
    Jansson SP, Svärdsudd K, Andersson DK.
    Diabet Med; 2014 Sep 05; 31(9):1055-63. PubMed ID: 24894815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.